• Je něco špatně v tomto záznamu ?

Management of mild cognitive impairment (MCI): The need for national and international guidelines

S. Kasper, C. Bancher, A. Eckert, H. Förstl, L. Frölich, J. Hort, AD. Korczyn, RW. Kressig, O. Levin, MSM. Palomo

. 2020 ; 21 (8) : 579-594. [pub] 20200205

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21012111

Objectives: To review available evidence of pharmacological and non-pharmacological treatment for MCI and analyse information and limitations in national and international guidelines.Methods: Experts from several European countries conducted a qualitative review of the literature on MCI and treatments for MCI, as well as respective chapters in national and international guidelines on dementia/MCI. Psychotherapeutic/psychosocial treatments were excluded from the review.Results: Consensus diagnostic criteria for MCI are available, making early recognition and accurate classification of MCI subtypes possible. MCI can be identified in a primary care setting. Further corroboration and differential diagnosis should be done at specialist level. Mixed pathologies are the rule in MCI, thus a multi-target treatment approach is a rational strategy. Promising evidence has been generated for multi-domain interventions. Limited evidence is available for different pharmacological classes that have been investigated in MCI clinical trials (e.g. acetylcholinesterase inhibitors). EGb 761® improved symptoms in some clinical trials; it is the only pharmacological treatment recommended in existing guidelines for the symptomatic treatment of MCI.Conclusions: MCI is recognised as an important treatment target and some recent national guidelines have considered symptomatic treatment recommendations for MCI. However, more needs to be done, especially at an international level.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012111
003      
CZ-PrNML
005      
20210507104852.0
007      
ta
008      
210420s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/15622975.2019.1696473 $2 doi
035    __
$a (PubMed)32019392
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Kasper, Siegfried $u Center for Brain Research, Medical University of Vienna, Vienna, Austria
245    10
$a Management of mild cognitive impairment (MCI): The need for national and international guidelines / $c S. Kasper, C. Bancher, A. Eckert, H. Förstl, L. Frölich, J. Hort, AD. Korczyn, RW. Kressig, O. Levin, MSM. Palomo
520    9_
$a Objectives: To review available evidence of pharmacological and non-pharmacological treatment for MCI and analyse information and limitations in national and international guidelines.Methods: Experts from several European countries conducted a qualitative review of the literature on MCI and treatments for MCI, as well as respective chapters in national and international guidelines on dementia/MCI. Psychotherapeutic/psychosocial treatments were excluded from the review.Results: Consensus diagnostic criteria for MCI are available, making early recognition and accurate classification of MCI subtypes possible. MCI can be identified in a primary care setting. Further corroboration and differential diagnosis should be done at specialist level. Mixed pathologies are the rule in MCI, thus a multi-target treatment approach is a rational strategy. Promising evidence has been generated for multi-domain interventions. Limited evidence is available for different pharmacological classes that have been investigated in MCI clinical trials (e.g. acetylcholinesterase inhibitors). EGb 761® improved symptoms in some clinical trials; it is the only pharmacological treatment recommended in existing guidelines for the symptomatic treatment of MCI.Conclusions: MCI is recognised as an important treatment target and some recent national guidelines have considered symptomatic treatment recommendations for MCI. However, more needs to be done, especially at an international level.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a Alzheimerova nemoc $x diagnóza $x farmakoterapie $x terapie $7 D000544
650    _2
$a kognitivní dysfunkce $x klasifikace $x diagnóza $x farmakoterapie $x terapie $7 D060825
650    _2
$a konsensus $7 D032921
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a mezinárodní spolupráce $7 D007391
650    _2
$a mužské pohlaví $7 D008297
650    12
$a směrnice pro lékařskou praxi jako téma $7 D017410
651    _2
$a Evropa $7 D005060
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bancher, Christian $u Department of Neurology/Neurological Rehabilitation, Landesklinikum Horn-Allentsteig, Horn, Austria
700    1_
$a Eckert, Anne $u Neurobiology Lab for Brain Aging and Mental Health, Transfaculty Research Platform Molecular & Cognitive Neuroscience (MCN), University of Basel, Psychiatric University Clinics Basel, Basel, Switzerland
700    1_
$a Förstl, Hans $u Clinic and Polyclinic for Psychiatry and Psychotherapy, Technical University of Munich, Klinikum rechts der Isar, Munich, Germany
700    1_
$a Frölich, Lutz $u Department of Gerontopsychiatry, Central Institute of Mental Health Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
700    1_
$a Hort, Jakub $u Department of Neurology, Charles University, 2nd Medical Faculty, and Motol University Hospital, Prague, Czech Republic $u International Clinical Research Centre, Brno, Czechia
700    1_
$a Korczyn, Amos D $u Department of Neurology, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel
700    1_
$a Kressig, Reto W $u University Department of Geriatric Medicine FELIX PLATTER, University of Basel, Basel, Switzerland
700    1_
$a Levin, Oleg $u Russian Medical Academy of Continuous Professional Education, Moscow, Russia
700    1_
$a Palomo, María Sagrario Manzano $u Neurology Department, Hospital Infanta Leonor, Madrid, Spain
773    0_
$w MED00176986 $t The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry $x 1814-1412 $g Roč. 21, č. 8 (2020), s. 579-594
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32019392 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507104850 $b ABA008
999    __
$a ok $b bmc $g 1650484 $s 1132490
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 21 $c 8 $d 579-594 $e 20200205 $i 1814-1412 $m The world journal of biological psychiatry $n World J Biol Psychiatry $x MED00176986
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...